Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-07-08
2008-07-08
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S356100, C548S373100, C548S376100, C514S403000, C424S001370
Reexamination Certificate
active
10537282
ABSTRACT:
The present invention is directed to a compound, {2-Methyl-4-[3-methyl-1-(4-trifluoromethyl-phenyl)-1H-pyrazol-4-ylmethylsulfanyl]-phenoxy}-acetic acid and pharmaceutical uses thereof.
REFERENCES:
patent: 6458744 (2002-10-01), Wu et al.
patent: 2006/0148858 (2006-07-01), Takeda
patent: 2006/0241157 (2006-10-01), Lilly
patent: 0442448 (1991-12-01), None
patent: 0442448 (1991-12-01), None
patent: 11130753 (1999-05-01), None
patent: WO 01/16120 (2001-03-01), None
patent: WO 02/100403 (2002-12-01), None
Conner Scott Eugene
Mantlo Nathan Bryan
Mayhugh Daniel Ray
Zhu Guoxin
Eli Lilly and Company
Shameem Golam M. M.
Vorndran-Jones MaCharri
LandOfFree
Pyrazole derivative as PPAR modulator does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazole derivative as PPAR modulator, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazole derivative as PPAR modulator will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3918544